The demand for GLP-1 receptor agonists is growing due to the favorable policies from various government institutions across the globe
People who spent decades in a cycle of restriction, overeating, guilt, and repeat find that the cycle simply stops
Novo and rival Eli Lilly, which makes the weight-loss drug Zepbound, have filed a flurry of lawsuits against medical spas, wellness clinics and compounding pharmacies for allegedly selling products claiming to contain the active ingredients in their drugs
Breath + Core Coordination Learning how your diaphragm, core, and pelvic floor work together
Future directions include CRISPR-edited exosome carriers and AI-designed nanoparticles to personalize combination regimens, bridging the gap between preclinical success and clinical translation (Table 1)